Fluorescence-Guided Surgery to Improve Sarcoma Tumor Removal
Treatments studied
Part of Cancer clinical trials.
This trial tests a special dye and imaging technique to help surgeons see and remove sarcoma tumors more completely. The goal is to reduce the chance that cancer cells are accidentally left behind during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with intermediate or high-grade sarcoma (a type of soft tissue or bone cancer) confirmed by biopsy
- Planning to have surgery with the goal of curing the cancer, not for comfort care only
- Tumor must be in an accessible location (not in the brain, deep belly area, or internal organs)
- Willing to complete surveys during the trial and allow doctors to review your medical records
- Cannot be pregnant or breastfeeding at the time of surgery
- No known allergies to iodine, iodine dyes, shellfish, or indocyanine green (ICG), a fluorescent dye used in the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special dye that helps surgeons see the edges of sarcoma tumors during surgery. It may help them remove all the cancer while saving healthy tissue.
This Phase 2 study tests whether using a fluorescent dye during tumor surgery can help the surgical team better see where the tumor ends. It may help aim for complete removal and lower the chance of the tumor coming back.
This trial tests whether taking a special medication (5-ALA) before surgery makes the sarcoma glow under a special light, helping the surgeon see and remove the cancer more completely. The goal is to reduce the chance of leaving any cancer behind.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This trial tests a new imaging system that helps surgeons see if cancer cells remain after breast-conserving surgery. It may reduce the need for a second surgery by giving real-time feedback on the removed tissue.
This study tests whether using a special dye during surgery helps doctors see and remove sarcoma tumors more completely. It may help improve the chances that no cancer is left behind.
Hear when a new High Grade Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.